Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | GALR3 | O60755 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | PRKCA | P17252 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4400024 | 0.86 | ALDH1A1 (0.32) | TSHRALDH1A1LMNAHSD17B10TDP1 | |
| SCHEMBL11124575 | 0.83 | ALDH1A1 (0.42) | TSHRALDH1A1PRKCA | |
| SCHEMBL2802408 | 0.83 | ALDH1A1 (0.42) | TSHRALDH1A1PRKCA | |
| SCHEMBL861924 | 0.83 | ALDH1A1 (0.36) | TSHRALDH1A1LMNAHSD17B10TDP1 | |
| SCHEMBL11428709 | 0.83 | TDP1 (0.47) | TSHRALDH1A1LMNAHSD17B10TDP1 | |
| Acetic Acid SCHEMBL10508445 | 0.83 | ALDH1A1 (0.37) | TSHRALDH1A1LMNAHSD17B10THRB | |
| SCHEMBL27750573 | 0.81 | THRB (0.46) | TSHRALDH1A1THRB | |
| SCHEMBL202380 | 0.80 | ALDH1A1 (0.40) | TSHRALDH1A1LMNAHSD17B10TDP1 | |
| SCHEMBL7709890 | 0.80 | ALDH1A1 (0.40) | TSHRALDH1A1LMNAHSD17B10TDP1 | |
| SCHEMBL3764178 | 0.80 | THRB (0.30) | THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1270549-B1 | POLYMER-IMMOBILIZED ALPHA-IMINOESTER | JAPAN SCIENCE & TECH AGENCY (JP) | 2009-05-20 | — | — | EP | claimed |
| EP-1270549-B1 | POLYMER-IMMOBILIZED ALPHA-IMINOESTER | JAPAN SCIENCE & TECH AGENCY (JP) | 2009-05-20 | — | — | EP | disclosed |
| US-6838527-B2 | Polymer-immobilized α-iminoester | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2005-01-04 | — | — | US | disclosed |
| US-20030187147-A1 | Polymer-immobilized alpha-iminoester | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2003-10-02 | — | — | US | disclosed |
| EP-1270549-A1 | POLYMER-IMMOBILIZED ALPHA-IMINOESTER | Japan Science and Technology Corporation (JP) | 2003-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030187147-A1 | Polymer-immobilized alpha-iminoester | PADI1, ADH1A, IL4I1 | TSHR 1962/4885ALDH1A1 24/4885LMNA 825/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.